Live from the NIH registry
Studies recruiting near Leesburg right now
Top 25 of 150 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1064 — Ocoee, Florida (25.4 mi)
· Sponsor: Immunovant Sciences GmbH
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (11.1 mi)
· Sponsor: Boehringer Ingelheim
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
K2 Medical Research The Villages LLC — Lady Lake, Florida (10.5 mi)
· Sponsor: AC Immune SA
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease
Phase 2
Interventional 240 participants sought
Nature Coast Clinical Research - Inverness — Inverness, Florida (26.7 mi)
· Sponsor: Calico Life Sciences LLC
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Bristol-Myers Squibb
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lady Lake, Florida (10.5 mi)
· Sponsor: 89bio, Inc.
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer's Disease
Phase 2
Interventional 407 participants sought
Charter Research The Villages — The Villages, Florida (12.2 mi)
· Sponsor: Novartis Pharmaceuticals
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Ocoee, Florida (25.4 mi)
· Sponsor: AstraZeneca
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
West Orange Endocrinology — Ocoee, Florida (25.4 mi)
· Sponsor: Amgen
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Ocoee, Florida (25.4 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Lady Lake, Florida (10.5 mi)
· Sponsor: Akero Therapeutics, Inc
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Heart Failure With Reduced Ejection Fraction
Phase 1
Interventional 12 participants sought
Nature Coast Clinical Research LLC — Inverness, Florida (26.7 mi)
· Sponsor: Novartis Pharmaceuticals
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Tavares, Florida (10.6 mi)
· Sponsor: American Society of Clinical Oncology
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.7 mi)
· Sponsor: Janssen Research & Development, LLC
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
Depressive Symptoms, Urinary Incontinence
N/A
Interventional 60 participants sought
Luxury Psychiatry Clinic — Winter Garden, Florida (23.4 mi)
· Sponsor: BTL Industries Ltd.
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
K2 Medical Research - The Villages - Northeast 138th Lane- Site Number : 8400063 — Lady Lake, Florida (10.5 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: BioNTech SE
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Attention Deficit Disorder With Hyperactivity (ADHD)
Phase 2
Interventional 312 participants sought
Alkermes Investigational Site — Clermont, Florida (16.8 mi)
· Sponsor: Alkermes, Inc.
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Ocoee, Florida (25.4 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Charter Research - Lady Lake — The Villages, Florida (12.2 mi)
· Sponsor: Bristol-Myers Squibb
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Phase 3
Interventional 1,205 participants sought
Lakeview Institute of Clinical Research — Leesburg, Florida (3.2 mi)
· Sponsor: Eli Lilly and Company
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Florida Cancer Specialists -North - 1125 — The Villages, Florida (12.2 mi)
· Sponsor: OncoC4, Inc.
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Puma Biotechnology, Inc.
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology